BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 11487529)

  • 1. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins).
    Goppelt-Struebe M; Hahn A; Iwanciw D; Rehm M; Banas B
    Mol Pathol; 2001 Jun; 54(3):176-9. PubMed ID: 11376131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP.
    Heusinger-Ribeiro J; Eberlein M; Wahab NA; Goppelt-Struebe M
    J Am Soc Nephrol; 2001 Sep; 12(9):1853-1861. PubMed ID: 11518778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism.
    Watts KL; Spiteri MA
    Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1323-32. PubMed ID: 15298857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton.
    Hahn A; Heusinger-Ribeiro J; Lanz T; Zenkel S; Goppelt-Struebe M
    J Biol Chem; 2000 Dec; 275(48):37429-35. PubMed ID: 10976101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
    Laufs U; Liao JK
    J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of simvastatin on mesangial cells.
    Heusinger-Ribeiro J; Fischer B; Goppelt-Struebe M
    Kidney Int; 2004 Jul; 66(1):187-95. PubMed ID: 15200425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression.
    Black SA; Trackman PC
    J Biol Chem; 2008 Apr; 283(16):10835-47. PubMed ID: 18287089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
    Graness A; Giehl K; Goppelt-Struebe M
    Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-Ter-Vehn T; Katzenberger B; Han H; Grehn F; Schlunck G
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3955-60. PubMed ID: 18421080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
    Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
    Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells.
    Pozo M; de Nicolás R; Egido J; González-Cabrero J
    Eur J Pharmacol; 2006 Oct; 548(1-3):53-63. PubMed ID: 16973154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.